Rivotril 2.5 mg/ml oral solution

Rivotril is a well-known pharmaceutical product containing clonazepam, primarily used to treat seizure disorders and panic attacks. The brand was originally developed by the Swiss pharmaceutical giant Hoffmann-La Roche. For decades, it has been a staple in neurological and psychiatric treatment.

Today, the ownership and distribution of Rivotril vary significantly by region due to strategic divestments. While Roche remains the original creator, in many markets (including across Europe and parts of Latin America), the rights to the brand were acquired by Cheplapharm Arzneimittel GmbH, a German family-owned company specializing in legacy brands. Manufacturing takes place in various high-standard pharmaceutical facilities across Europe and other regulated regions to meet global demand.